在AML-MR中对CPX-351的现实世界分析:MARROW联盟的一项多中心研究
Daniel T Peters1, Deedra Nicolet2, Yazan F Madanat3
1University of North Carolina, Lineberger Comprehensive Cancer Center, Chapel Hill, North Carolina, USA.
British journal of haematology
|December 3, 2025
概括
在新诊断的急性骨髓性白血病中,CPX-351显示了52%的完全缓解率与骨髓张变化相关的变化 (AML-MR). 分子定义AML-MR (AML-MRm) 患者,特别是年轻患者,经历了更好的结果,建议量身定制的治疗.
科学领域:
- 血液学 血液学 血液学
- 在瘤学瘤学.
- 临床研究 临床研究
背景情况:
- CPX-351是一种标准的诱导治疗方案,用于治疗急性骨髓性白血病与骨髓质变化相关的变化 (AML-MRC).
- 最近的分类 (ICC/WHO 2022) 根据突变和细胞遗传学重新定义了与骨髓发育不良相关的AML (AML-MR).
- 根据这些新的AML-MR分类,CPX-351的临床结果尚未得到充分确立.
研究的目的:
- 评估新诊断的AML-MR患者用CPX-351.1.治疗的临床结果.
- 根据年龄和特定的AML-MR亚组 (细胞遗传,分子,先例疾病) 来分层结果.
- 评估精细分类对CPX-351治疗疗效的影响.
主要方法:
- 对235名新诊断AML-MR的成年人进行了回顾性多中心研究,他们接受了CPX-351.1.治疗.
- 根据年龄分层的患者 (<60 vs. ≥60岁) 和AML-MR亚组 (AML-MRc,AML-MRm,AML-AHD).
- 分析的结果包括完全缓解 (CR/CRi),全源干细胞移植 (alloHSCT) 率和整体存活率 (OS).
主要成果:
- 总体CR/CRi比率为52%,没有与年龄相关的差异.
- 在AML-MRm小组中,CR/CRi比率最高 (57%).
- 平均寿命为13.8个月;较年轻的AML-MRm患者的寿命明显更长 (38.0个月),相比较年长的AML-MRm患者 (19.5个月).
结论:
- 在新诊断的AML-MR中,CPX-351实现了52%的CR/CRi率.
- 分子分类 (AML-MRm) 与有利的结果有关,特别是在年轻的患者中.
- 分子分层可能指导CPX-351疗法,并支持其在老年人之外的使用.
更多相关视频
09:57Comprehensive Protocol to Sample and Process Bone Marrow for Measuring Measurable Residual Disease and Leukemic Stem Cells in Acute Myeloid Leukemia
Published on: March 5, 2018
06:33Identifying Bone Marrow Microenvironmental Populations in Myelodysplastic Syndrome and Acute Myeloid Leukemia
Published on: November 10, 2023
相关概念视频
Bone Marrow Sampling and Transplants
Bone marrow transplant is a potential cure for several diseases, including cancer and specific genetic disorders. Notably, this procedure is applicable for patients suffering from aplastic anemia, certain types of leukemia, severe combined immunodeficiency disease (SCID), Hodgkin's disease, non-Hodgkin's lymphoma, multiple myeloma, thalassemia, sickle-cell disease, and certain cancers.
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy the...
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy the...
Acute Coronary Syndrome III: Diagnostic Studies
Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...
